Détails du mandat
objet
Kendle International Inc. Acquires DecisionLine Clinical Research Corporation
CLIENT
Kendle International Inc.
DATE
2 juin 2008
EXPERTISE
Sciences de la vie, Fusions et acquisitions, Fiscalité, Droit des sociétés et droit commercial
AVOCAT(S)
Anthony Milazzo, Suzana Lobo, Alyssa Achong Low, Martha Healey, Paul Carenza, Michael Horvat
On June 2, 2008 Kendle International Inc. ("Kendle"), a leading global full-service clinical research organization ("CRO"), completed its acquisition of DecisionLine Clinical Research Corporation ("DecisionLine"), through a wholly owned Canadian subsidiary, for an undisclosed cash amount. DecisionLine is an early phase CRO specializing in conducting Phase I studies involving the measurement of pharmacodynamic effects of central nervous system drugs. Kendle's acquisition of DecisionLine represents a significant step in building Kendle's global capabilities for exploration of early phase drug candidates and supports its strategic initiative to drive the growth of its Phase I business.
In Canada, Kendle was represented by Ogilvy Renault LLP with a team comprised of Anthony Milazzo, Suzana Lobo and Alyssa Achong Low (M&A, Corporate/Commercial), Martha Healey (Regulatory), Paul Carenza (Tax) and Michael Horvat (Employment & Labour).
